U.S. equities experienced a day of notable volatility and mixed performance on Wednesday, September 17, 2025, as investors digested the Federal Reserve's latest interest rate decision and a flurry of corporate news. The blue-chip Dow Jones Industrial Average (DJIA) posted solid gains, reaching an intraday record high, while the broader S&P 500 (SPX) and the technology-heavy Nasdaq Composite (IXIC) edged lower, reflecting a divergence in market sentiment. The day's trading was largely dominated by the Federa ...

Nucor (NYSE:NUE) shares fell over 5% in extended trading on Wednesday after the steelmaker issued earnings guidance for the third quarter below Wall Street consensus. The company said it expects third-quarter earnings to be in the range of $2.05 to $2.15 per ...

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants losing 20% or more body weight1**Oral semaglutide 25 mg also demonstrated improvements in the ability to perform everyday physical activities such as bending, standing, walking, being physically active, and improvements in cardiovascular risk factors1Oral semaglutide 25 mg is the first oral GLP-1 therapy submitted to the US Food and Drug Administration (FDA) for chronic ...

Calgary, Alberta--(Newsfile Corp. - September 17, 2025) - Canadian Critical Minerals Inc. (TSXV: CCMI) (OTCQB: RIINF) ("CCMI" or the "Company") announces a flow-through financing for gross proceeds of $600,000, comprised of 17,142,858 flow-through units with an issue price of $0.035 per unit. Each unit will consist of one flow-through share and one-half of one common share purchase warrant that is exercisable into a common share at an exercise price of $0.05 cents per share for a period of three years. Clo ...

Accessibility StatementSkip Navigation 23 Consecutive Quarter of a Consistent Dividend PHOENIX, Sept. 17, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity Capital" or "the Company"), a leading alternative asset manager, today announced that its Board of Directors declared a cash dividend of $0.51 per share with respect to the quarter ending September 30, 2025. This is an equivalent dividend compared to the second quarter of 2025 and marks the 23rd consecutive quarter of a consistent or i ...

Expectations for falling rates have helped drive stocks to records. ...

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team ...

Shares of ConocoPhillips (NYSE: COP ) have been a poor performer over the past year, losing about 13% of their value. A difficult commodity price environment has been the primary impediment, with operating metrics largely solid. I last covered ConocoOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just ...

Shares of ConocoPhillips (NYSE: COP ) have been a poor performer over the past year, losing about 13% of their value. A difficult commodity price environment has been the primary impediment, with operating metrics largely solid. I last covered ConocoOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just ...

NEW YORK and NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL). On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifically, lowering its 2023 Medical Margin expectation to “$340 million to $360 million, approximately $110 milli ...